We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
(+7.6%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$43.6M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$39.6M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$36.1M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$35.4M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$41.5M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$36.1M |
| 3 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$27.3M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$22.9M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.43% |
| 2 | Financials | 4.62% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Healthcare | 3.87% |
| 5 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.33B
| $5.08M | 0.02% |
55,254
+14,856
| +37% | +$1.3M |
|
652
Exelon
EXC
$46.6B
| $5.07M | 0.02% |
124,365
+9,940
| +9% | +$411K |
|
653
Diageo
DEO
$52.2B
| $5.07M | 0.02% |
29,197
-2,915
| -9% | -$520K |
|
654
Innovator US Equity Power Buffer ETF December
PDEC
$997M
| $5.06M | 0.02% |
151,923
+70
| +0% | +$2.23K |
|
655
Eastman Chemical
EMN
$8.29B
| $5.05M | 0.02% |
60,333
-14,564
| -19% | -$1.18M |
|
656
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $5.03M | 0.02% |
85,320
-184,316
| -68% | -$11M |
|
657
Alliant Energy
LNT
$18.2B
| $5.03M | 0.02% |
95,741
+4,589
| +5% | +$246K |
|
658
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
$534M
| $5M | 0.02% |
90,432
+600
| +0.7% | +$33.9K |
|
659
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
| $4.99M | 0.02% |
96,276
+21,544
| +29% | +$1.12M |
|
660
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$427M
| $4.98M | 0.02% |
80,806
-10,631
| -12% | -$654K |
|
661
iShares MSCI ACWI ETF
ACWI
$33.4B
| $4.97M | 0.02% |
51,818
-11,339
| -18% | -$1.05M |
|
662
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$779M
| $4.97M | 0.02% |
33,457
+1,372
| +4% | +$196K |
|
663
Graco
GGG
$13.4B
| $4.95M | 0.02% |
57,338
-14,291
| -20% | -$1.11M |
|
664
AutoZone
AZO
$49.7B
| $4.93M | 0.02% |
1,978
-416
| -17% | -$1.06M |
|
665
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.74B
| $4.93M | 0.02% |
164,891
-4,212
| -2% | -$126K |
|
666
Nuveen Municipal Value Fund
NUV
$1.89B
| $4.92M | 0.02% |
565,635
+11,990
| +2% | +$105K |
|
667
Global X Cybersecurity ETF
BUG
$1.5B
| $4.92M | 0.02% |
202,745
+5,449
| +3% | +$126K |
|
668
Conagra Brands
CAG
$7.16B
| $4.92M | 0.02% |
145,872
-4,517
| -3% | -$163K |
|
669
DuPont de Nemours
DD
$19.5B
| $4.91M | 0.02% |
54,788
+183
| +0.3% | +$15.7K |
|
670
IQVIA
IQV
$39.8B
| $4.91M | 0.02% |
21,835
+1,077
| +5% | +$216K |
|
671
Vale
VALE
$61.4B
| $4.91M | 0.02% |
365,476
-167,440
| -31% | -$2.37M |
|
672
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
| $4.89M | 0.02% |
31,958
+1,750
| +6% | +$273K |
|
|
ETW
673
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.07B
| $4.89M | 0.02% |
594,851
-2,627
| -0.4% | -$21.3K |
|
|
HFRO
674
Highland Opportunities and Income Fund
HFRO
$398M
| $4.88M | 0.02% |
540,729
-14,741
| -3% | -$129K |
|
675
Invesco S&P SmallCap Quality ETF
XSHQ
$320M
| $4.88M | 0.02% |
135,276
-1,625
| -1% | -$54.5K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
- Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
- Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
- Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
- Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
- Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.